[HTML][HTML] Autophagy in Parkinson's disease

X Hou, JO Watzlawik, FC Fiesel, W Springer - Journal of molecular biology, 2020 - Elsevier
Impaired protein homeostasis and accumulation of damaged or abnormally modified protein
are common disease mechanisms in many neurodegenerative disorders, including …

Mitochondrial dysfunction and oxidative stress in Parkinson's disease

SR Subramaniam, MF Chesselet - Progress in neurobiology, 2013 - Elsevier
Parkinson's disease (PD) is a movement disorder that is characterized by the progressive
degeneration of dopaminergic neurons in substantia nigra pars compacta resulting in …

Structure of LRRK2 in Parkinson's disease and model for microtubule interaction

CK Deniston, J Salogiannis, S Mathea, DM Snead… - Nature, 2020 - nature.com
Leucine-rich repeat kinase 2 (LRRK2) is the most commonly mutated gene in familial
Parkinson's disease and is also linked to its idiopathic form. LRRK2 has been proposed to …

Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease

MH Yan, X Wang, X Zhu - Free Radical Biology and Medicine, 2013 - Elsevier
Alzheimer disease (AD) and Parkinson disease (PD) are the two most common age-related
neurodegenerative diseases characterized by prominent neurodegeneration in selective …

Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences

N Exner, AK Lutz, C Haass, KF Winklhofer - The EMBO journal, 2012 - embopress.org
Neurons are critically dependent on mitochondrial integrity based on specific morphological,
biochemical, and physiological features. They are characterized by high rates of metabolic …

[HTML][HTML] What genetics tells us about the causes and mechanisms of Parkinson's disease

O Corti, S Lesage, A Brice - Physiological reviews, 2011 - journals.physiology.org
Parkinson's disease (PD) is a common motor disorder of mysterious etiology. It is due to the
progressive degeneration of the dopaminergic neurons of the substantia nigra and is …

[PDF][PDF] Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression

P Reinhardt, B Schmid, LF Burbulla, DC Schöndorf… - Cell stem cell, 2013 - cell.com
Summary The LRRK2 mutation G2019S is the most common genetic cause of Parkinson's
disease (PD). To better understand the link between mutant LRRK2 and PD pathology, we …

[HTML][HTML] LRRK2 Biology from structure to dysfunction: research progresses, but the themes remain the same

DC Berwick, GR Heaton, S Azeggagh… - Molecular …, 2019 - Springer
Since the discovery of leucine-rich repeat kinase 2 (LRRK2) as a protein that is likely central
to the aetiology of Parkinson's disease, a considerable amount of work has gone into …

Effect of selective LRRK2 kinase inhibition on nonhuman primate lung

RN Fuji, M Flagella, M Baca, MA S. Baptista… - Science translational …, 2015 - science.org
Inhibition of the kinase activity of leucine-rich repeat kinase 2 (LRRK2) is under investigation
as a possible treatment for Parkinson's disease. However, there is no clinical validation as …

Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update

K Nuytemans, J Theuns, M Cruts… - Human …, 2010 - Wiley Online Library
To date, molecular genetic analyses have identified over 500 distinct DNA variants in five
disease genes associated with familial Parkinson disease; α‐synuclein (SNCA), parkin …